162 related articles for article (PubMed ID: 10496436)
1. Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope.
Foglia-Manzillo G; Giada F; Beretta S; Corrado G; Santarone M; Raviele A
Am J Cardiol; 1999 Aug; 84(3):284-8. PubMed ID: 10496436
[TBL] [Abstract][Full Text] [Related]
2. Methodology of head-up tilt testing potentiated with sublingual nitroglycerin in unexplained syncope.
Del Rosso A; Bartoletti A; Bartoli P; Ungar A; Bonechi F; Maioli M; Ieri A
Am J Cardiol; 2000 Apr; 85(8):1007-11. PubMed ID: 10760344
[TBL] [Abstract][Full Text] [Related]
3. Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope.
Foglia-Manzillo G; Giada F; Fteita N; Nessi I; Santarone M; Raviele A
Eur Heart J; 2007 Nov; 28(21):2605-9. PubMed ID: 17911368
[TBL] [Abstract][Full Text] [Related]
4. Tilt test in elderly patients with syncope of unknown etiology: experience with pharmacological stimulation with nitroglycerin.
Timóteo AT; Oliveira MM; Antunes E; Vieira AP; Feliciano J; Fiarresga AJ; Silva S; Coito S; Quininha J
Rev Port Cardiol; 2005; 24(7-8):945-53. PubMed ID: 16240681
[TBL] [Abstract][Full Text] [Related]
5. Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope.
Raviele A; Menozzi C; Brignole M; Gasparini G; Alboni P; Musso G; Lolli G; Oddone D; Dinelli M; Mureddu R
Am J Cardiol; 1995 Aug; 76(4):267-72. PubMed ID: 7618622
[TBL] [Abstract][Full Text] [Related]
6. Shortened head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope.
Del Rosso A; Bartoli P; Bartoletti A; Brandinelli-Geri A; Bonechi F; Maioli M; Mazza F; Michelucci A; Russo L; Salvetti E; Sansoni M; Zipoli A; Fierro A; Ieri A
Am Heart J; 1998 Apr; 135(4):564-70. PubMed ID: 9539468
[TBL] [Abstract][Full Text] [Related]
7. Specificity and total positive rate of head-up tilt testing potentiated with sublingual nitroglycerin in older patients with unexplained syncope.
Mussi C; Tolve I; Foroni M; Valli A; Ascari S; Salvioli G
Aging (Milano); 2001 Apr; 13(2):105-11. PubMed ID: 11405383
[TBL] [Abstract][Full Text] [Related]
8. Study of the efficiency of the head-up tilt test with nitroglycerin challenge in the diagnosis of vasovagal syncope.
Podoleanu C; Frigy A; Dobreanu D; Micu S; Podoleanu D; Incze A; Caraşca E
Rom J Intern Med; 2004; 42(3):585-94. PubMed ID: 16366132
[TBL] [Abstract][Full Text] [Related]
9. Comparison of diagnostic accuracy of sublingual nitroglycerin test and low-dose isoproterenol test in patients with unexplained syncope.
Raviele A; Giada F; Brignole M; Menozzi C; Marangoni E; Manzillo GF; Alboni P
Am J Cardiol; 2000 May; 85(10):1194-8. PubMed ID: 10802000
[TBL] [Abstract][Full Text] [Related]
10. Use of sublingual nitroglycerin during head-up tilt-table testing in patients >60 years of age.
Natale A; Sra J; Akhtar M; Kusmirek L; Tomassoni G; Leonelli F; Newby K; Beheiry S; Pacifico A
Am J Cardiol; 1998 Nov; 82(10):1210-3. PubMed ID: 9832096
[TBL] [Abstract][Full Text] [Related]
11. Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response?
Russo V; Papa AA; Ciardiello C; Rago A; Proietti R; Calabrò P; Russo MG; Nigro G
Pacing Clin Electrophysiol; 2015 Apr; 38(4):507-13. PubMed ID: 25684414
[TBL] [Abstract][Full Text] [Related]
12. Tilt testing potentiated with sublingual nitroglycerin in children with unexplained syncope.
Jastrzebska-Maj E; Mizia-Stec K; Jakubowski D
Eur Heart J; 2008 Apr; 29(8):1074-5; author reply 1075. PubMed ID: 18339608
[No Abstract] [Full Text] [Related]
13. [Head-up tilt testing potentiated with sublingual nitroglycerin for the diagnosis of unexplained syncope in children].
Zhang QY; Du JB; Li WZ
Zhonghua Er Ke Za Zhi; 2004 May; 42(5):371-4. PubMed ID: 15189698
[TBL] [Abstract][Full Text] [Related]
14. Duration of head-up tilt test for patients with suspected vasovagal syncope.
Liu J; Fang P; Liu Y; Lu G; Li Z; Li X; Wang Y
Europace; 2011 Apr; 13(4):576-80. PubMed ID: 21357590
[TBL] [Abstract][Full Text] [Related]
15. Use of nitroglycerin in the active phase of tilt testing: is there a difference in elderly patients?
Timóteo AT; Oliveira M; Antunes E; Pelicano N; Feliciano J; Silva S; Ferreira R; Quininha J
Rev Port Cardiol; 2007 Apr; 26(4):321-30. PubMed ID: 17695728
[TBL] [Abstract][Full Text] [Related]
16. What is the optimal duration of the TILT after administration of 0.4 mg nitroglycerin spray?
Glockler A; Cismaru G; Istratoaie S; Gusetu G; Zdrenghea D; Pop D; Rosu R
Medicine (Baltimore); 2020 Mar; 99(11):e19510. PubMed ID: 32176097
[TBL] [Abstract][Full Text] [Related]
17. Poor diagnostic performance of tilt testing in hypertensive patients with unexplained syncope.
Ungar A; Rafanelli M; Cellai T; Ceccofiglio A; Del Rosso A; Mussi C; Marchionni N
J Hum Hypertens; 2014 Apr; 28(4):259-62. PubMed ID: 24132139
[TBL] [Abstract][Full Text] [Related]
18. 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope.
Bartoletti A; Alboni P; Ammirati F; Brignole M; Del Rosso A; Foglia Manzillo G; Menozzi C; Raviele A; Sutton R
Europace; 2000 Oct; 2(4):339-42. PubMed ID: 11194602
[TBL] [Abstract][Full Text] [Related]
19. Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol.
Russo V; Parente E; Tomaino M; Comune A; Sabatini A; Laezza N; Carretta D; Nigro G; Rago A; Golino P; Brignole M
Eur Heart J; 2023 Jul; 44(27):2473-2479. PubMed ID: 37264671
[TBL] [Abstract][Full Text] [Related]
20. Late hemodynamic changes during a negative passive head-up tilt predict the symptomatic outcome to a nitroglycerin sensitized tilt.
Bellard E; Fortrat JO; Schang D; Dupuis JM; Victor J; Lefthériotis G
Pacing Clin Electrophysiol; 2005 Feb; 28(2):89-96. PubMed ID: 15679637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
